Primer ID Ultra-Deep Sequencing Reveals Dynamics of Drug Resistance-Associated Variants in Breakthrough Hepatitis C Viruses: Relevance to Treatment Outcome and Resistance Screening

Antiviral Therapy - United Kingdom
doi 10.3851/imp3056
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Medical Press

Related search

Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2015English

Viral Determinants of Resistance to Treatment in Patients With Hepatitis C

Clinical Microbiology Reviews
ImmunologyEnvironmentalPublic HealthMicrobiologyMicrobiology EpidemiologyInfectious DiseasesOccupational Health
2007English

Comparison of the Mechanisms of Drug Resistance Among HIV, Hepatitis B, and Hepatitis C

Viruses
VirologyInfectious Diseases
2010English

Prevalence of Resistance Associated Substitutions and Efficacy of Baseline Resistance-Guided Chronic Hepatitis C Treatment in Spain From the GEHEP-004 Cohort

PLoS ONE
Multidisciplinary
2019English

Hepatitis C Virus Resistance to Antiviral Therapy

Hepatology
MedicineHepatology
2000English

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure

Viruses
VirologyInfectious Diseases
2016English

Virologic Failures on Initial Boosted-Pi Regimen Infrequently Possess Low-Level Variants With Major PI Resistance Mutations by Ultra-Deep Sequencing

PLoS ONE
Multidisciplinary
2012English

Hepatitis B: Treatment Strategies and Resistance

Retrovirology
VirologyInfectious Diseases
2010English

Evaluation of Persistence of Resistant Variants With Ultra-Deep Pyrosequencing in Chronic Hepatitis C Patients Treated With Telaprevir

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy